Kumar view

Bank of Baroda (BOB),(3rd Largest PSU Bank), has announced its plan to raise additional capital of up to Rs 5,000 crore through debt capital instruments, according to the Board meeting held today on June 2, 2023. The Board of Directors of Bank of Baroda approved the capital raising, which will be done through the issuance of Additional Tier I (AT I) or Tier II debt capital instruments. The bank's Board has provided the flexibility to raise capital either in India or overseas, in suitable tranches, by the end of the ongoing financial year 2023-24, and potentially beyond if deemed beneficial. Bank of Baroda has emphasized that it will raise the additional capital when market conditions are favorable. In terms of financial performance, Bank of Baroda witnessed an impressive surge in net profit during the March 2023 quarter. The net profit soared by a remarkable 168.4% to reach Rs 4,775 crore, compared to Rs 1,779 crore in the same period last year. Moreover, the net interest margin (N...

Himadri Speciality Chemical Ltd. is a small cap company with market cap of 5528 Cr. Himadri Speciality Chemical Ltd. stock price surge 1.5 % on Wednesday and closed at 127.85.   In a Press release They informed exchanged that  Himadri Speciality Chemical Ltd. has made an investment (in cash) of AUD 10.32 Million in Sicona Battery Technologies Pty Ltd (“Sicona”) for acquiring 12.79% shareholding in Sicona.  Sicona is a Sydney based battery-technology company which develops next generation battery materials technology used in the anodes (negative electrodes) of lithium-ion (“Li-ion”) batteries that enable electric-mobility and storage of renewable energy. Sicona is commercialising an innovative siliconcomposite battery anode materials technology, developed and perfected at the Australian Institute for Innovative Materials (AIIM). Sicona’s current generation silicon-composite anode technology delivers 50% to 100% higher capacity than conventional graphite anod...

The Indian government has recently disclosed significant details regarding the fiscal deficit for the financial year 2022-23. During this period, the fiscal deficit reached 6.4 percent of the country's GDP. The Ministry of Finance, in its revised estimate, aimed to maintain the same fiscal deficit target. These figures were derived from government data released on Wednesday. Notably, the fiscal deficit in FY23 amounted to Rs 17.33 lakh crore, approximately 98.7 percent of the budget estimate. To bridge this deficit, the government sought to borrow funds from the market. Budget Aligned with Expectations In FY2023, the fiscal deficit reached 98.7 percent of the estimated budget. Moreover, the revenue deficit accounted for 96.2 percent of the projected amount, while the primary deficit represented 98.8 percent of the budget estimate. Interest payments aligned with expectations at 98.7 percent of the budget estimate, and capital expenditure slightly exceeded projections at 101.2 percen...

  In the fast-paced world of stock trading, pharmaceutical companies often emerge as some of the most lucrative investment options. With their potential for groundbreaking medical advancements, expanding global reach, and ever-increasing demand for healthcare products, pharma stocks have become a favorite among investors. A small cap pharmaceutical  Stock  “Marksans Pharma” is grabbing investor attention. Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products.   The stock price surge 7 % during today’s trading session and closed at 81.05 with an eye-catching traded volume of 18.93 M which is almost 7.5X the average volume of 10 days. Milestone   Since incorporation in 2001, Marksans Pharma has undergone various phases of transformation, consolidation, mergers and acquisitions. From its initial identity of being a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., the organization has grown from strength-to-strength t...

  Amidst the recession chaos in global Market, India looks like a safer bet in comparison for the foreign Investors and the benchmark index Nifty-50 performance in recent times supporting this feeling.   With the shareholding data for Q-4 FY-2023 release, sharing few stocks that have seen the highest rise in Foreign institutional investor (FII) Holdings. In this blog, will discuss the stocks that FII shown their interest in Q-4, with strong performance and which also outperformed Nifty-50 Index.   Equitas Small Finance Bank   Equitas Small Finance Bank saw the highest rise in FII holding, with an increase of 18.61% QoQ to reach 22.69% in Q4FY23. The bank’s stock price surged 17% over the past month, boosted by strong Q4FY23 results. Annual Revenue  rose 20.9%, in the last year to Rs 4,831.5 Crores. Its sector's average revenue growth for the last fiscal year was 9.4%. Annual Net Profit  rose 104.3% in the last year to Rs 573.6 Crores. Its...

  One of the most common Myth in investing is the idea that you must work with a financial advisor in order to make good investments. Perhaps this myth has persisted for so long, kudos to marketing endeavor of financial advisory firms . However, the reality is that investors who manage their own money are often able to perform better than those who work with a financial advisor. If you’re still in the dilemma about whether or not you need a financial advisor to be a successful investor or reach your financial goals, consider these points.   Advisor Never Try to Beat the Market Performance Financial advisors act more as a mentor, consistent guide, counselor helping each one of us set our financials goals, guiding us through tough times and persuading not to make emotional decisions. Beating market is not actually advisor job. You need to decide yourself if this mentoring service is worth paying 1% of the portfolio for every year. Financial Advisors Charge irre...

  While creating a long-term portfolio, it is very important to select financially strong companies that can bear ups and down and stand tall amidst all odd. While financial year 2023 was a tough year on account of high inflation, geopolitical tensions, rising interest rates, etc. some companies remained intact and went on to deliver their record performance in terms of revenues. Here are three Nifty-50 companies, that closed FY-23 with their highest respective revenue.   Reliance Industries Limited Reliance is a household name and no long-term portfolio of large caps can be completed without this giant stock. Reliance Industries Ltd is India’s largest company with a market capitalization of INR 1,695,959.05 crores and reported an all-time high revenue of INR 8,91,294 crores, which was a noticeable 24.1% YoY jump. This kind of growth is generally not seen in a mega-cap company. If you think that’s a one-time gain, the 5-year CAGR of revenue is also 20.4%. Reliance has ...